Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Preserving patient protections in a repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409)) Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Education Training Act (H.R. 1676/S. 693)) Reform and sustainability of the 340B Program
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2018 · first_quarter · 1A
Preserving patient protections in a repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Palliative Care and Hospice Education and Training Act
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409)) Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Education Training Act (H.R. 1676/S. 693)) Reform and sustainability of the 340B Program
Cancer Care Planning and Communications Act of 2018
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Excluding Part B payments from CMS' Merit Based Incentive Payment System (MIPS) adjustment under the Quality Payment Program (QPP) Reimbursement for care planning for cancer patients in the Medicare Program (The Cancer Care Planning & Communications (CCPC) Act (H.R. 5160))
Palliative Care and Hospice Education and Training Act
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409)) Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Education Training Act (H.R. 1676/S. 693)) Reform and sustainability of the 340B Program
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Preserving patient protections in a repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Cancer Drug Parity Act of 2017
Client: ASSOCIATION OF COMMUNITY CANCER CENTERS · Firm: (C) MANAGEMENT INC.
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2018 · first_quarter · Q1
Excluding Part B payments from CMS' Merit Based Incentive Payment System (MIPS) adjustment under the Quality Payment Program (QPP) Reimbursement for care planning for cancer patients in the Medicare Program (The Cancer Care Planning & Communications (CCPC) Act (H.R. 5160))
Oral chemotherapy parity legislation (The Cancer Drug Parity Act of 2017 (H.R. 1409)) Increased education and training for medical professionals in palliative care (The Palliative Care & Hospice Education Training Act (H.R. 1676/S. 693)) Reform and sustainability of the 340B Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2017 · fourth_quarter · Q4
Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)
Preserving patient protections in a repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2017 · third_quarter · Q3
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2017 · second_quarter · Q2
Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2017 · first_quarter · Q1
Flexibility in implementing CMS' Quality Payment Program Limiting the role of the Center for Medicare and Medicaid Innovation (CMMI)
Repeal of the Affordable Care Act (ACA) Oral chemotherapy parity legislation (H.R. 1409, the Cancer Drug Parity Act of 2017)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2016 · fourth_quarter · Q4
The Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) rules The Part B Drug Payment Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2016 · third_quarter · Q3
The Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) rules The Part B Drug Payment Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF COMMUNITY CANCER CENTERS via (C) MANAGEMENT INC.
2016 · third_quarter · RR
Medicare Hospital Outpatient Prospective Payment System and Physician Fee Schedule. CMS proposed reimbursement and coverage decisions impacting cancer care. Oncology-specific alternative payment models and value-based payment approaches. CMS proposed Quality Payment Program. Oral parity legislation.
Medicare Hospital Outpatient Prospective Payment System and Physician Fee Schedule. CMS proposed reimbursement and coverage decisions impacting cancer care. Oncology-specific alternative payment models and value-based payment approaches. CMS proposed Quality Payment Program. Oral parity legislation.